Categories AlphaGraphs, Earnings, Health Care
CVS Earnings: CVS Health Q3 adj. profit drops despite 6% revenue growth
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced third-quarter 2024 results, reporting a decrease in adjusted earnings and an increase in revenues. The top line exceeded estimates.
September-quarter adjusted profit decreased 51% year-over-year to $1.09 per share and missed analysts’ estimates. On a reported basis, net income was $87 million or $0.07 per share in Q3, compared to $2.26 billion or $1.75 per share in the prior-year quarter.
Meanwhile, revenues increased 6% year-over-year to $95.4 billion during the three months and topped expectations. Total same-store sales climbed 15.5% year-over-year.
“My commitment to our CVS Health colleagues and our customers is to drive focused execution of our integrated strategy to improve the health of the 185 million people we are privileged to serve.,” said CVS CEO David Joyner.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
DIS Earnings: All you need to know about Walt Disney’s Q4 2025 earnings results
The Walt Disney Company (NYSE: DIS) reported its fourth quarter 2025 earnings results today. Revenues of $22.5 billion were comparable to the year-ago quarter. Net income attributable to The Walt
Cisco (CSCO) reports higher Q1 revenue and earnings; results beat estimates
Network gear maker Cisco Systems Inc. (NASDAQ: CSCO) on Wednesday announced financial results for the first quarter of fiscal 2026, reporting higher revenue and profit. Earnings, on an adjusted basis,
Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO
CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on hematologic malignancies and solid tumors. In an email conversation with
